P55290 (CAD13_HUMAN) Reviewed, UniProtKB/Swiss-Prot
Last modified
January 25, 2012.
Version 113.
History...
Names·Attributes·General annotation·Ontologies·Sequence annotation·Sequences·References·Cross-refs·Entry info·DocumentsCustomize order
Names·Attributes·General annotation·Ontologies·Sequence annotation·Sequences·References·Cross-refs·Entry info·DocumentsCustomize orderNames and origin
| Protein names | Recommended name: Cadherin-13 Alternative name(s): Heart cadherin Short name=H-cadherin P105 Truncated cadherin Short name=T-cad Short name=T-cadherin | ||||
| Gene names |
| ||||
| Organism | Homo sapiens (Human) | ||||
| Taxonomic identifier | 9606 [NCBI] | ||||
| Taxonomic lineage | Eukaryota › Metazoa › Chordata › Craniata › Vertebrata › Euteleostomi › Mammalia › Eutheria › Euarchontoglires › Primates › Haplorrhini › Catarrhini › Hominidae › Homo |
Protein attributes
| Sequence length | 713 AA. |
| Sequence status | Complete. |
| Sequence processing | The displayed sequence is further processed into a mature form. |
| Protein existence | Evidence at protein level |
General annotation (Comments)
| Function | Cadherins are calcium dependent cell adhesion proteins. They preferentially interact with themselves in a homophilic manner in connecting cells; cadherins may thus contribute to the sorting of heterogeneous cell types. May act as a negative regulator of neural cell growth. Ref.6 |
| Subcellular location | |
| Tissue specificity | Highly expressed in heart. In the CNS, expressed in cerebral cortex, medulla, hippocampus, amygdala, thalamus and substantia nigra. No expression detected in cerebellum or spinal cord. Ref.2 Ref.6 |
| Developmental stage | Expressed at higher levels in adult brain than in developing brain. Ref.6 |
| Sequence similarities | Contains 5 cadherin domains. |
Ontologies
Sequence annotation (Features)
| Feature key | Position(s) | Length | Description | Graphical view | Feature identifier | ||||||||||||||||||||||||||||
Molecule processing | |||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Signal peptide | 1 – 22 | 22 | Potential | ||||||||||||||||||||||||||||||
| Propeptide | 23 – 138 | 116 | PRO_0000003793 | ||||||||||||||||||||||||||||||
| Chain | 139 – 693 | 555 | Cadherin-13 | PRO_0000003794 | |||||||||||||||||||||||||||||
| Propeptide | 694 – 713 | 20 | Removed in mature form Probable | PRO_0000003795 | |||||||||||||||||||||||||||||
Regions | |||||||||||||||||||||||||||||||||
| Domain | 139 – 245 | 107 | Cadherin 1 | ||||||||||||||||||||||||||||||
| Domain | 246 – 363 | 118 | Cadherin 2 | ||||||||||||||||||||||||||||||
| Domain | 364 – 477 | 114 | Cadherin 3 | ||||||||||||||||||||||||||||||
| Domain | 478 – 585 | 108 | Cadherin 4 | ||||||||||||||||||||||||||||||
| Domain | 584 – 694 | 111 | Cadherin 5 | ||||||||||||||||||||||||||||||
Amino acid modifications | |||||||||||||||||||||||||||||||||
| Lipidation | 693 | 1 | GPI-anchor amidated glycine Probable | ||||||||||||||||||||||||||||||
| Glycosylation | 52 | 1 | N-linked (GlcNAc...) Potential | ||||||||||||||||||||||||||||||
| Glycosylation | 86 | 1 | N-linked (GlcNAc...) Ref.8 | ||||||||||||||||||||||||||||||
| Glycosylation | 382 | 1 | N-linked (GlcNAc...) Potential | ||||||||||||||||||||||||||||||
| Glycosylation | 500 | 1 | N-linked (GlcNAc...) Ref.8 | ||||||||||||||||||||||||||||||
| Glycosylation | 530 | 1 | N-linked (GlcNAc...) Ref.10 | ||||||||||||||||||||||||||||||
| Glycosylation | 598 | 1 | N-linked (GlcNAc...) Potential | ||||||||||||||||||||||||||||||
| Glycosylation | 638 | 1 | N-linked (GlcNAc...) Ref.8 Ref.10 | ||||||||||||||||||||||||||||||
| Glycosylation | 671 | 1 | N-linked (GlcNAc...) Potential | ||||||||||||||||||||||||||||||
Natural variations | |||||||||||||||||||||||||||||||||
| Natural variant | 65 | 1 | R → C in a patient with amyotrophic lateral sclerosis. Ref.11 | VAR_065747 | |||||||||||||||||||||||||||||
| Natural variant | 103 | 1 | A → V in a patient with amyotrophic lateral sclerosis. Ref.11 | VAR_065748 | |||||||||||||||||||||||||||||
| Natural variant | 113 | 1 | G → R in a patient with amyotrophic lateral sclerosis. Ref.11 | VAR_065749 | |||||||||||||||||||||||||||||
| Natural variant | 121 | 1 | L → S. Corresponds to variant rs7197352 [ dbSNP | Ensembl ]. | VAR_030632 | |||||||||||||||||||||||||||||
| Natural variant | 246 | 1 | R → W in a patient with amyotrophic lateral sclerosis. Ref.11 | VAR_065750 | |||||||||||||||||||||||||||||
| Natural variant | 367 | 1 | E → Q in a patient with amyotrophic lateral sclerosis. Ref.11 | VAR_065751 | |||||||||||||||||||||||||||||
| Natural variant | 376 | 1 | A → T. Ref.11 Corresponds to variant rs35549391 [ dbSNP | Ensembl ]. | VAR_065752 | |||||||||||||||||||||||||||||
| Natural variant | 643 | 1 | L → R. Ref.11 Corresponds to variant rs34106627 [ dbSNP | Ensembl ]. | VAR_065753 | |||||||||||||||||||||||||||||
Experimental info | |||||||||||||||||||||||||||||||||
| Sequence conflict | 199 | 1 | V → M in AAH28624. Ref.4 | ||||||||||||||||||||||||||||||
| Sequence conflict | 199 | 1 | V → M in AAH30653. Ref.4 | ||||||||||||||||||||||||||||||
| Sequence conflict | 288 | 1 | Q → R in AAH28624. Ref.4 | ||||||||||||||||||||||||||||||
| Sequence conflict | 288 | 1 | Q → R in AAH30653. Ref.4 | ||||||||||||||||||||||||||||||
| Sequence conflict | 392 | 1 | T → A in AAH28624. Ref.4 | ||||||||||||||||||||||||||||||
| Sequence conflict | 392 | 1 | T → A in AAH30653. Ref.4 | ||||||||||||||||||||||||||||||
| Sequence conflict | 544 | 1 | P → T in AAH28624. Ref.4 | ||||||||||||||||||||||||||||||
| Sequence conflict | 544 | 1 | P → T in AAH30653. Ref.4 | ||||||||||||||||||||||||||||||
Secondary structure | |||||||||||||||||||||||||||||||||
Helix Strand Turn | |||||||||||||||||||||||||||||||||
| Beta strand | 145 – 148 | 4 | |||||||||||||||||||||||||||||||
| Beta strand | 157 – 161 | 5 | |||||||||||||||||||||||||||||||
| Beta strand | 163 – 167 | 5 | |||||||||||||||||||||||||||||||
| Beta strand | 172 – 178 | 7 | |||||||||||||||||||||||||||||||
| Turn | 179 – 181 | 3 | |||||||||||||||||||||||||||||||
| Beta strand | 182 – 184 | 3 | |||||||||||||||||||||||||||||||
| Beta strand | 187 – 190 | 4 | |||||||||||||||||||||||||||||||
| Turn | 192 – 194 | 3 | |||||||||||||||||||||||||||||||
| Beta strand | 196 – 199 | 4 | |||||||||||||||||||||||||||||||
| Turn | 205 – 207 | 3 | |||||||||||||||||||||||||||||||
| Beta strand | 209 – 218 | 10 | |||||||||||||||||||||||||||||||
| Beta strand | 224 – 236 | 13 | |||||||||||||||||||||||||||||||
| Beta strand | 238 – 241 | 4 | |||||||||||||||||||||||||||||||
Sequences
| ||||||||||||||||||
References
| « Hide 'large scale' references | |
| [1] | "Cloning of five human cadherins clarifies characteristic features of cadherin extracellular domain and provides further evidence for two structurally different types of cadherin." Tanihara H., Sano K., Heimark R.L., St John T., Suzuki S. Cell Adhes. Commun. 2:15-26(1994) [PubMed: 7982033] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [MRNA]. Tissue: Brain. |
| [2] | "H-cadherin, a novel cadherin with growth inhibitory functions and diminished expression in human breast cancer." Lee S.W. Nat. Med. 2:776-782(1996) [PubMed: 8673923] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [MRNA], TISSUE SPECIFICITY. |
| [3] | "The H-cadherin (CDH13) gene is inactivated in human lung cancer." Sato M., Mori Y., Sakurada A., Fujimura S., Horii A. Hum. Genet. 103:96-101(1998) [PubMed: 9737784] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [GENOMIC DNA]. |
| [4] | "The status, quality, and expansion of the NIH full-length cDNA project: the Mammalian Gene Collection (MGC)." The MGC Project Team Genome Res. 14:2121-2127(2004) [PubMed: 15489334] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA]. Tissue: Brain and Testis. |
| [5] | "Identification of an atypical lipoprotein-binding protein from human aortic smooth muscle as T-cadherin." Tkachuk V.A., Bochkov V.N., Philippova M.P., Stambolsky D.V., Kuzmenko E.S., Sidorova M.V., Molokoedov A.S., Spirov V.G., Resink T.J. FEBS Lett. 421:208-212(1998) [PubMed: 9468307] [Abstract] Cited for: PROTEIN SEQUENCE OF 140-149; 162-169 AND 284-287. Tissue: Aorta. |
| [6] | "Expression of T-cadherin (CDH13, H-Cadherin) in human brain and its characteristics as a negative growth regulator of epidermal growth factor in neuroblastoma cells." Takeuchi T., Misaki A., Liang S.-B., Tachibana A., Hayashi N., Sonobe H., Ohtsuki Y. J. Neurochem. 74:1489-1497(2000) [PubMed: 10737605] [Abstract] Cited for: FUNCTION, TISSUE SPECIFICITY, DEVELOPMENTAL STAGE. Tissue: Brain. |
| [7] | "The glycosyl phosphatidylinositol anchor of human T-cadherin binds lipoproteins." Niermann T., Kern F., Erne P., Resink T. Biochem. Biophys. Res. Commun. 276:1240-1247(2000) [PubMed: 11027617] [Abstract] Cited for: CHARACTERIZATION. |
| [8] | "Human plasma N-glycoproteome analysis by immunoaffinity subtraction, hydrazide chemistry, and mass spectrometry." Liu T., Qian W.-J., Gritsenko M.A., Camp D.G. II, Monroe M.E., Moore R.J., Smith R.D. J. Proteome Res. 4:2070-2080(2005) [PubMed: 16335952] [Abstract] Cited for: GLYCOSYLATION [LARGE SCALE ANALYSIS] AT ASN-86; ASN-500 AND ASN-638, MASS SPECTROMETRY. Tissue: Plasma. |
| [9] | "Modification-specific proteomics of plasma membrane proteins: identification and characterization of glycosylphosphatidylinositol-anchored proteins released upon phospholipase D treatment." Elortza F., Mohammed S., Bunkenborg J., Foster L.J., Nuehse T.S., Brodbeck U., Peck S.C., Jensen O.N. J. Proteome Res. 5:935-943(2006) [PubMed: 16602701] [Abstract] Cited for: GPI-ANCHOR [LARGE SCALE ANALYSIS], MASS SPECTROMETRY. Tissue: Cervix carcinoma. |
| [10] | "Glycoproteomics analysis of human liver tissue by combination of multiple enzyme digestion and hydrazide chemistry." Chen R., Jiang X., Sun D., Han G., Wang F., Ye M., Wang L., Zou H. J. Proteome Res. 8:651-661(2009) [PubMed: 19159218] [Abstract] Cited for: GLYCOSYLATION [LARGE SCALE ANALYSIS] AT ASN-530 AND ASN-638, MASS SPECTROMETRY. Tissue: Liver. |
| [11] | "Resequencing of 29 candidate genes in patients with familial and sporadic amyotrophic lateral sclerosis." Daoud H., Valdmanis P.N., Gros-Louis F., Belzil V., Spiegelman D., Henrion E., Diallo O., Desjarlais A., Gauthier J., Camu W., Dion P.A., Rouleau G.A. Arch. Neurol. 68:587-593(2011) [PubMed: 21220648] [Abstract] Cited for: VARIANTS CYS-65; VAL-103; ARG-113; TRP-246; GLN-367; THR-376 AND ARG-643. |
| + | Additional computationally mapped references. |
Cross-references
Sequence databases | |||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| EMBL GenBank DDBJ | L34058 mRNA. Translation: AAA35624.1. U59289 mRNA. Translation: AAB18912.1. U59288 mRNA. Translation: AAB18911.1. AB001103 Genomic DNA. Translation: BAA32411.1. BC028624 mRNA. Translation: AAH28624.1. BC030653 mRNA. Translation: AAH30653.1. | ||||||||||||
| IPI | IPI01013272. | ||||||||||||
| PIR | B38992. | ||||||||||||
| RefSeq | NP_001248.1. NM_001257.4. | ||||||||||||
| UniGene | Hs.654386. Hs.661776. | ||||||||||||
3D structure databases | |||||||||||||
| PDBe RCSB PDB PDBj |
| ||||||||||||
| ProteinModelPortal | P55290. | ||||||||||||
| SMR | P55290. Positions 23-680. | ||||||||||||
| ModBase | Search... | ||||||||||||
Protein-protein interaction databases | |||||||||||||
| STRING | P55290. | ||||||||||||
PTM databases | |||||||||||||
| PhosphoSite | P55290. | ||||||||||||
Polymorphism databases | |||||||||||||
| DMDM | 1705552. | ||||||||||||
Proteomic databases | |||||||||||||
| PeptideAtlas | P55290. | ||||||||||||
| PRIDE | P55290. | ||||||||||||
Protocols and materials databases | |||||||||||||
| StructuralBiologyKnowledgebase | Search... | ||||||||||||
Genome annotation databases | |||||||||||||
| Ensembl | ENST00000268613; ENSP00000268613; ENSG00000140945. | ||||||||||||
| GeneID | 1012. | ||||||||||||
| KEGG | hsa:1012. | ||||||||||||
| UCSC | uc002fgx.1. human. | ||||||||||||
Organism-specific databases | |||||||||||||
| CTD | 1012. | ||||||||||||
| GeneCards | GC16P082660. | ||||||||||||
| H-InvDB | HIX0202308. | ||||||||||||
| HGNC | HGNC:1753. CDH13. | ||||||||||||
| HPA | CAB025863. HPA001380. | ||||||||||||
| MIM | 601364. gene. | ||||||||||||
| neXtProt | NX_P55290. | ||||||||||||
| PharmGKB | PA26287. | ||||||||||||
| GenAtlas | Search... | ||||||||||||
Phylogenomic databases | |||||||||||||
| eggNOG | prNOG13954. | ||||||||||||
| GeneTree | ENSGT00550000074431. | ||||||||||||
| HOVERGEN | HBG106438. | ||||||||||||
| InParanoid | P55290. | ||||||||||||
| OrthoDB | EOG498V07. | ||||||||||||
Enzyme and pathway databases | |||||||||||||
| Reactome | REACT_111155. Cell-Cell communication. | ||||||||||||
Gene expression databases | |||||||||||||
| ArrayExpress | P55290. | ||||||||||||
| Bgee | P55290. | ||||||||||||
| CleanEx | HS_CDH13. | ||||||||||||
| Genevestigator | P55290. | ||||||||||||
Family and domain databases | |||||||||||||
| InterPro | IPR002126. Cadherin. IPR015919. Cadherin-like. IPR015489. Cadherin13. IPR020894. Cadherin_CS. IPR014868. Cadherin_pro_dom. [Graphical view] | ||||||||||||
| Gene3D | G3DSA:2.60.40.60. Cadherin. 5 hits. | ||||||||||||
| KO | K06808. | ||||||||||||
| PANTHER | PTHR24027:SF39. PTHR24027:SF39. 1 hit. | ||||||||||||
| Pfam | PF00028. Cadherin. 5 hits. PF08758. Cadherin_pro. 1 hit. [Graphical view] | ||||||||||||
| PRINTS | PR00205. CADHERIN. | ||||||||||||
| SMART | SM00112. CA. 5 hits. SM01055. Cadherin_pro. 1 hit. [Graphical view] | ||||||||||||
| SUPFAM | SSF49313. Cadherin. 6 hits. | ||||||||||||
| PROSITE | PS00232. CADHERIN_1. 3 hits. PS50268. CADHERIN_2. 5 hits. [Graphical view] | ||||||||||||
| ProtoNet | Search... | ||||||||||||
Other | |||||||||||||
| NextBio | 4253. | ||||||||||||
| SOURCE | Search... | ||||||||||||
Entry information
| Entry name | CAD13_HUMAN | ||||||||
| Accession | Primary (citable) accession number: P55290 Secondary accession number(s): Q6GTW4, Q8TBX3 | ||||||||
| Entry history |
| ||||||||
| Entry status | Reviewed (UniProtKB/Swiss-Prot) | ||||||||
| Annotation program | Chordata Protein Annotation Program | ||||||||
| Disclaimer | Any medical or genetic information present in this entry is provided for research, educational and informational purposes only. It is not in any way intended to be used as a substitute for professional medical advice, diagnosis, treatment or care. | ||||||||
Relevant documents
| Human chromosome 16 Human chromosome 16: entries, gene names and cross-references to MIM |
| Human entries with polymorphisms or disease mutations List of human entries with polymorphisms or disease mutations |
| Human polymorphisms and disease mutations Index of human polymorphisms and disease mutations |
| MIM cross-references Online Mendelian Inheritance in Man (MIM) cross-references in UniProtKB/Swiss-Prot |
| PDB cross-references Index of Protein Data Bank (PDB) cross-references |
| SIMILARITY comments Index of protein domains and families |

Clusters with